As climate change worsens respiratory diseases, doctors and drugmakers are exploring earlier diagnosis and low-carbon ...

A global contract development and manufacturing organization focused on drug-device combination products. The company ...

Bespak are a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and ...

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives used a conference presentation to highlight the company’s shift toward ...

Detailed price information for Medipharm Labs Corp (MEDIF) from The Globe and Mail including charting and trades.

MediPharm Labs’ proven ability to navigate complex regulatory environments enables us to deliver GMP-certified cannabinoid ...

Researchers from UCLA and other health institutions found that some inhalers produce significant greenhouse gas emissions, highlighting the need for health care providers to consider their carbon ...

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study—the largest to date quantifying inhaler-related emissions ...